HALO logo

Halozyme Therapeutics, Inc. (HALO) Operating Profit

Annual Operating Profit:

$551.48M+$213.90M(+63.36%)
December 31, 2024

Summary

  • As of today, HALO annual operating income is $551.48 million, with the most recent change of +$213.90 million (+63.36%) on December 31, 2024.
  • During the last 3 years, HALO annual operating profit has risen by +$275.57 million (+99.88%).
  • HALO annual operating profit is now at all-time high.

Performance

HALO Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALOincome statement metrics

Quarterly Operating Profit:

$202.44M+$60.91M(+43.03%)
June 30, 2025

Summary

  • As of today, HALO quarterly operating income is $202.44 million, with the most recent change of +$60.91 million (+43.03%) on June 30, 2025.
  • Over the past year, HALO quarterly operating profit has increased by +$85.21 million (+72.68%).
  • HALO quarterly operating profit is now at all-time high.

Performance

HALO Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALOincome statement metrics

TTM Operating Profit:

$682.67M+$85.21M(+14.26%)
June 30, 2025

Summary

  • As of today, HALO TTM operating income is $682.67 million, with the most recent change of +$85.21 million (+14.26%) on June 30, 2025.
  • Over the past year, HALO TTM operating profit has increased by +$280.58 million (+69.78%).
  • HALO TTM operating profit is now at all-time high.

Performance

HALO TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALOincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

HALO Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+63.4%+72.7%+69.8%
3Y3 Years+99.9%+494.4%+182.3%
5Y5 Years+915.7%+585.0%+1874.8%

HALO Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+106.1%at high+276.3%at high+177.9%
5Y5-Yearat high+915.7%at high+494.4%at high+1874.8%
All-TimeAll-Timeat high+762.8%at high+731.4%at high+794.3%

HALO Operating Profit History

DateAnnualQuarterlyTTM
Jun 2025
-
$202.44M(+43.0%)
$682.67M(+14.3%)
Mar 2025
-
$141.53M(-19.4%)
$597.47M(+8.3%)
Dec 2024
$551.48M(+63.4%)
$175.50M(+7.5%)
$551.48M(+15.6%)
Sep 2024
-
$163.20M(+39.2%)
$477.01M(+18.6%)
Jun 2024
-
$117.23M(+22.7%)
$402.09M(+6.0%)
Mar 2024
-
$95.54M(-5.4%)
$379.31M(+12.4%)
Dec 2023
$337.57M(+26.2%)
$101.03M(+14.4%)
$337.57M(+8.5%)
Sep 2023
-
$88.28M(-6.5%)
$311.05M(+1.6%)
Jun 2023
-
$94.46M(+75.6%)
$306.06M(+24.6%)
Mar 2023
-
$53.80M(-27.8%)
$245.66M(-8.2%)
Dec 2022
$267.53M(-3.0%)
$74.51M(-10.5%)
$267.53M(+7.2%)
Sep 2022
-
$83.29M(+144.5%)
$249.56M(+3.2%)
Jun 2022
-
$34.06M(-55.0%)
$241.85M(-19.6%)
Mar 2022
-
$75.67M(+33.8%)
$300.84M(+9.0%)
Dec 2021
$275.90M(+91.3%)
$56.53M(-25.2%)
$275.90M(-7.1%)
Sep 2021
-
$75.59M(-18.8%)
$296.99M(+13.5%)
Jun 2021
-
$93.05M(+83.4%)
$261.70M(+32.0%)
Mar 2021
-
$50.73M(-34.6%)
$198.21M(+37.4%)
Dec 2020
$144.25M(+313.4%)
$77.62M(+92.6%)
$144.25M(+317.3%)
Sep 2020
-
$40.30M(+36.4%)
$34.57M(+214.2%)
Jun 2020
-
$29.55M(+1017.0%)
-$30.27M(+59.0%)
Mar 2020
-
-$3.22M(+89.9%)
-$73.80M(-9.2%)
Dec 2019
-$67.61M(+2.5%)
-$32.06M(-30.7%)
-$67.61M(-89.8%)
Sep 2019
-
-$24.54M(-75.6%)
-$35.62M(+2.6%)
Jun 2019
-
-$13.98M(-571.2%)
-$36.56M(+14.3%)
Mar 2019
-
$2.97M(+4277.5%)
-$42.65M(+38.5%)
Dec 2018
-$69.33M(-185.6%)
-$71.00K(+99.7%)
-$69.33M(-222.3%)
Sep 2018
-
-$25.47M(-26.9%)
$56.67M(-37.2%)
Jun 2018
-
-$20.07M(+15.3%)
$90.22M(+6.4%)
Mar 2018
-
-$23.71M(-118.8%)
$84.82M(+4.7%)
Dec 2017
$81.00M(+197.3%)
$125.93M(+1459.1%)
$81.00M(+220.0%)
Sep 2017
-
$8.08M(+131.7%)
-$67.50M(+31.3%)
Jun 2017
-
-$25.48M(+7.4%)
-$98.32M(-4.0%)
Mar 2017
-
-$27.53M(-21.9%)
-$94.57M(-13.6%)
Dec 2016
-$83.21M(-203.1%)
-$22.57M(+0.7%)
-$83.21M(-50.8%)
Sep 2016
-
-$22.74M(-4.7%)
-$55.17M(+0.9%)
Jun 2016
-
-$21.72M(-34.3%)
-$55.66M(-87.4%)
Mar 2016
-
-$16.17M(-395.9%)
-$29.71M(-8.2%)
Dec 2015
-$27.45M(+56.5%)
$5.46M(+123.5%)
-$27.45M(+25.3%)
Sep 2015
-
-$23.24M(-649.2%)
-$36.77M(-12.9%)
Jun 2015
-
$4.23M(+130.4%)
-$32.56M(+37.1%)
Mar 2015
-
-$13.91M(-261.2%)
-$51.73M(+17.9%)
Dec 2014
-$63.04M(+21.6%)
-$3.85M(+79.8%)
-$63.04M(+21.7%)
Sep 2014
-
-$19.03M(-27.3%)
-$80.51M(-0.7%)
Jun 2014
-
-$14.94M(+40.8%)
-$79.98M(+8.2%)
Mar 2014
-
-$25.22M(-18.3%)
-$87.16M(-8.4%)
Dec 2013
-$80.43M
-$21.32M(-15.3%)
-$80.43M(-26.6%)
DateAnnualQuarterlyTTM
Sep 2013
-
-$18.49M(+16.4%)
-$63.52M(+2.4%)
Jun 2013
-
-$22.12M(-19.6%)
-$65.05M(-14.2%)
Mar 2013
-
-$18.50M(-319.7%)
-$56.98M(-6.3%)
Dec 2012
-$53.63M(-170.3%)
-$4.41M(+78.0%)
-$53.63M(+20.7%)
Sep 2012
-
-$20.03M(-42.6%)
-$67.65M(-59.3%)
Jun 2012
-
-$14.05M(+7.2%)
-$42.46M(-67.7%)
Mar 2012
-
-$15.14M(+17.8%)
-$25.32M(-27.6%)
Dec 2011
-$19.84M(+63.4%)
-$18.43M(-457.6%)
-$19.84M(-2.8%)
Sep 2011
-
$5.15M(+66.4%)
-$19.29M(+47.7%)
Jun 2011
-
$3.10M(+132.0%)
-$36.88M(+29.3%)
Mar 2011
-
-$9.66M(+46.0%)
-$52.13M(+3.9%)
Dec 2010
-$54.26M(+7.2%)
-$17.88M(-43.8%)
-$54.26M(-10.6%)
Sep 2010
-
-$12.43M(-2.3%)
-$49.05M(+3.0%)
Jun 2010
-
-$12.15M(-3.1%)
-$50.56M(+8.9%)
Mar 2010
-
-$11.79M(+7.0%)
-$55.49M(+5.1%)
Dec 2009
-$58.46M(-15.9%)
-$12.68M(+9.1%)
-$58.46M(+6.9%)
Sep 2009
-
-$13.94M(+18.4%)
-$62.81M(-4.6%)
Jun 2009
-
-$17.08M(-15.8%)
-$60.07M(-10.5%)
Mar 2009
-
-$14.76M(+13.3%)
-$54.36M(-7.8%)
Dec 2008
-$50.43M(-79.2%)
-$17.03M(-52.0%)
-$50.43M(-16.4%)
Sep 2008
-
-$11.20M(+1.5%)
-$43.34M(-7.1%)
Jun 2008
-
-$11.37M(-5.0%)
-$40.45M(-15.9%)
Mar 2008
-
-$10.83M(-9.1%)
-$34.90M(-24.0%)
Dec 2007
-$28.15M(-80.6%)
-$9.93M(-19.5%)
-$28.15M(-23.0%)
Sep 2007
-
-$8.31M(-42.5%)
-$22.89M(-24.4%)
Jun 2007
-
-$5.83M(-42.9%)
-$18.41M(-15.1%)
Mar 2007
-
-$4.08M(+12.6%)
-$15.99M(-2.6%)
Dec 2006
-$15.58M(-14.9%)
-$4.67M(-22.0%)
-$15.58M(-7.5%)
Sep 2006
-
-$3.83M(-12.0%)
-$14.49M(-0.4%)
Jun 2006
-
-$3.42M(+7.0%)
-$14.43M(-3.4%)
Mar 2006
-
-$3.67M(-2.6%)
-$13.96M(-3.0%)
Dec 2005
-$13.56M(-49.2%)
-$3.58M(+5.0%)
-$13.56M(-8.4%)
Sep 2005
-
-$3.77M(-27.8%)
-$12.51M(-4.2%)
Jun 2005
-
-$2.95M(+9.9%)
-$12.01M(-7.7%)
Mar 2005
-
-$3.27M(-29.4%)
-$11.15M(-22.7%)
Dec 2004
-$9.09M(>-9900.0%)
-$2.53M(+22.5%)
-$9.09M(-64.4%)
Sep 2004
-
-$3.26M(-56.2%)
-$5.53M(-106.8%)
Jun 2004
-
-$2.09M(-73.0%)
-$2.67M(-179.5%)
Mar 2004
-
-$1.21M(-217.0%)
-$956.20K(>-9900.0%)
Dec 2003
$0.00(0.0%)
$1.03M(+352.9%)
$0.00(+100.0%)
Sep 2003
-
-$408.20K(-9.5%)
-$1.01M(-64.0%)
Jun 2003
-
-$372.90K(-48.3%)
-$618.40K(-134.4%)
Mar 2003
-
-$251.40K(-1458.9%)
-$263.80K(>-9900.0%)
Dec 2002
$0.00(+100.0%)
$18.50K(+246.8%)
$0.00(+100.0%)
Sep 2002
-
-$12.60K(+31.1%)
-$18.50K(-213.6%)
Jun 2002
-
-$18.30K(-247.6%)
-$5900.00(-147.6%)
Mar 2002
-
$12.40K
$12.40K
Dec 2001
-$39.70K
-
-

FAQ

  • What is Halozyme Therapeutics, Inc. annual operating income?
  • What is the all-time high annual operating profit for Halozyme Therapeutics, Inc.?
  • What is Halozyme Therapeutics, Inc. annual operating profit year-on-year change?
  • What is Halozyme Therapeutics, Inc. quarterly operating income?
  • What is the all-time high quarterly operating profit for Halozyme Therapeutics, Inc.?
  • What is Halozyme Therapeutics, Inc. quarterly operating profit year-on-year change?
  • What is Halozyme Therapeutics, Inc. TTM operating income?
  • What is the all-time high TTM operating profit for Halozyme Therapeutics, Inc.?
  • What is Halozyme Therapeutics, Inc. TTM operating profit year-on-year change?

What is Halozyme Therapeutics, Inc. annual operating income?

The current annual operating profit of HALO is $551.48M

What is the all-time high annual operating profit for Halozyme Therapeutics, Inc.?

Halozyme Therapeutics, Inc. all-time high annual operating income is $551.48M

What is Halozyme Therapeutics, Inc. annual operating profit year-on-year change?

Over the past year, HALO annual operating income has changed by +$213.90M (+63.36%)

What is Halozyme Therapeutics, Inc. quarterly operating income?

The current quarterly operating profit of HALO is $202.44M

What is the all-time high quarterly operating profit for Halozyme Therapeutics, Inc.?

Halozyme Therapeutics, Inc. all-time high quarterly operating income is $202.44M

What is Halozyme Therapeutics, Inc. quarterly operating profit year-on-year change?

Over the past year, HALO quarterly operating income has changed by +$85.21M (+72.68%)

What is Halozyme Therapeutics, Inc. TTM operating income?

The current TTM operating profit of HALO is $682.67M

What is the all-time high TTM operating profit for Halozyme Therapeutics, Inc.?

Halozyme Therapeutics, Inc. all-time high TTM operating income is $682.67M

What is Halozyme Therapeutics, Inc. TTM operating profit year-on-year change?

Over the past year, HALO TTM operating income has changed by +$280.58M (+69.78%)
On this page